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Genetic biomarkers in the over 40s in Northern Ireland: evidence from
the Northern Ireland COhort of Longitudinal study of Ageing (NICOLA)
Marisa Cañadas-Garre*, Laura J Smyth, Frank Kee, Ian Young, AJ McKnight on behalf of the
Northern Ireland COhort of Longitudinal Ageing collaborative group#
Centre for Public Health, Queen’s University Belfast, Northern Ireland, UK
The Northern Ireland COhort of Longitudinal study
of Ageing (NICOLA) is a population-based
prospective cohort study, formally launched as
Northern Ireland’s largest ever public health
research project in 2014, and representative of the
community living older population (>40 years) in
Northern Ireland.
Chronic kidney disease (CKD) is an important
public health problem affecting up to 10% of
adults worldwide. CKD and classic polygenic traits
as lipid levels and anthropomorphic traits are
highly heritable, with many common associated
variants identified through genome-wide
association (GWA) studies.
The aim of this study is to identify biomarkers associated with CKD, lipid
levels and anthropomorphic traits in older adults in Northern Ireland and
to describe a genomic profile of this population.
This is a cross-sectional study using biomolecular and clinical data from
2,807 patients from the first Wave of data collection in NICOLA.
Demographic and clinical information was collected with follow-up
interviews planned every two years and health assessments every four
years. A range of phenotypes was investigated: CKD (estimated
glomerular filtration rate (eGFR), creatinine, cystatin C, CKD stage), lipid
levels (total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-
density lipoprotein cholesterol (HDL-C), and triglyceride (TG) levels),
anthropomorphic traits (height, body mass index, waist-hip ratio).
DNA was extracted from buffy coats. Genotype data (n=551,839 markers)
was generated using Illumina’s Infinium CoreExome-24 BeadChips for
high-throughput screening on an iScan. Quality control (QC) was
performed in PLINK and association analysis (logistic or linear regression)
in PLINK and R/SPSS.
Phenotype measures were obtained for 2,529
(kidney measures), 2,543 (lipid levels), and 2,488
(anthropomorphic traits) individuals after QC
(Table 1). Age and sex were employed as
covariates. Several markers in chromosomes 11,
16, and 19 were significantly associated with lipid
levels in this population (Table 2). No association
with genome-wide significance was identified for
kidney disease or anthropomorphic traits.
Some of the markers identified in this study in
older individuals confirm previous
associations with lipid levels in other
populations. Despite multiple loci being
identified in association with eGFR and CKD in
both European and non-European
populations, those were not replicated in this
study, likely as a consequence of the relatively
small number of individuals investigated in
NICOLA with this phenotype.
Phenotypes n mean Standard deviation median minimum maximum
An
th
ro
po
m
or
ph
ic 
Tr
ai
ts
Age (yrs) 2541 64.16 9.28 64.00 40.00 96.00
Body Masss Index (kg/m²) 2530 28.77 5.03 28.04 16.15 67.44
Weight (kg) 2530 79.47 16.27 78.00 39.40 174.80
Height (cm) 2534 165.97 9.27 165.75 141.00 199.00
Waist Circumference (cm) 2523 95.45 13.88 94.90 38.00 157.40
Hip (cm) 2523 104.68 9.47 103.40 47.50 181.95
Waist-Hip Ratio 2523 0.91 0.09 0.91 0.67 1.20
Lip
id
 Le
ve
ls Age (yrs) 2484 64.13 9.26 64.00 40.00 96.00Total Cholesterol (mg/dL) 2488 199.32 45.07 198.74 78.15 391.72
LDL-Cholesterol (mg/dL) 2431 111.49 38.31 110.59 6.99 279.87
HDL-Cholesterol (mg/dL) 2485 57.9 15.4 55.9 12.9 129.5
Triglycerides (mg/dL) 2488 152.67 88.21 133.92 21.34 878.70
Ki
dn
ey
 M
ea
su
re
s
Age (yrs) 2529 64.15 9.26 64.00 40.00 93.00
Creatinine (mg/dl) 2528 0.89 0.28 0.83 0.53 7.39
eGFR (EPI) 2529 80.87 15.84 83.91 4.99 118.09
CKD stage N %
1 825 32.70
2 1425 56.35
3A 199 7.87
3B 65 2.57
4 11 0.43
5 2 0.08
CKD: Chronic Kidney Disease; HDL: High Density Lipoprotein; LDL: Low Density Lipoprotein
Table 1. Clinical characteristics of the NICOLA participants
Chr Gene Variant Gene BETA P-value
Total 
Cholesterol
19 rs7412 APOE -13.62 5.34E-10
High Density 
Cholesterol
16 rs9989419 CETP -2.41 3.90E-09
16 rs173539 CETP 3.48 2.19E-15
16 rs247616 CETP 3.45 6.28E-15
16 rs247617 CETP 3.45 6.28E-15
16 rs183130 CETP 3.47 4.63E-15
16 rs3764261 CETP 3.47 4.59E-15
16 rs1800775 CETP 3.16 4.57E-15
16 rs9939224 CETP -3.75 5.43E-15
16 rs7205804 CETP 3.16 2.15E-14
16 rs1532624 CETP 3.23 4.61E-15
16 rs7499892 CETP -4.18 4.96E-16
16 exm1242986 CETP -5.22 2.13E-10
Low Density 
Cholesterol
19 rs7412 APOE -16.21 1.49E-17
19 rs445925 APOE -10.23 1.57E-09
Triglycerides 11 rs964184 ZPR1 23.50 9.46E-1019 rs7412 APOE -13.98 1.34E-11
Table 2. Association of gene variants with lipid levels
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